Dr. Jun Zhang’s project “ALCAT1 as a Novel Target for the Treatment of Cardiomyopathy in Barth Syndrome” has been accepted and fully funded for a two-year period by the Barth Syndrome Foundation. Dr. Zhang is an Instructor/Research in the lab of Dr. Yuguang Shi with the Sam and Ann Barshop Institute for Longevity and Aging Studies and the Department of Pharmacology.
Congratulations to Jun Zhang, PhD on his Barth Syndrome Foundation award!
